Pages that link to "Q35682682"

The following pages link to Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm (Q35682682):

Displaying 14 items.

• Coming of age: the artificial pancreas for type 1 diabetes (Q26745886) (← links)
• GLP-1 Agonists in Type 1 Diabetes Mellitus. (Q34677451) (← links)
• Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia. (Q35769584) (← links)
• Artificial Pancreas Project at Cambridge 2013 (Q35858586) (← links)
• Adjuvant Liraglutide and Insulin Versus Insulin Monotherapy in the Closed-Loop System in Type 1 Diabetes: A Randomized Open-Labeled Crossover Design Trial (Q37275418) (← links)
• The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema. (Q37652799) (← links)
• The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus. (Q38580783) (← links)
• Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes (Q38642435) (← links)
• Short-acting glucagon-like peptide-1 receptor agonists as add-on to insulin therapy in type 1 diabetes: A review. (Q39140474) (← links)
• The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes (Q39413453) (← links)
• Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas. (Q51654262) (← links)
• Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else? (Q52562630) (← links)
• Adjunctive therapy for glucose control in patients with type 1 diabetes. (Q55234623) (← links)
• Technology in the management of type 1 diabetes mellitus - current status and future prospects (Q56516887) (← links)